Silicon Valley Capital Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$490 Buy
82
+1
+1% +$8 ﹤0.01% 367
2025
Q4
$584 Hold
81
﹤0.01% 253
2025
Q3
$868 Buy
81
+35
+76% +$343 ﹤0.01% 268
2025
Q2
$449 Hold
46
﹤0.01% 295
2025
Q1
$672 Buy
46
+1
+2% +$15 ﹤0.01% 233
2024
Q4
$678 Hold
45
﹤0.01% 302
2024
Q3
$854 Buy
45
+1
+2% +$21 ﹤0.01% 297
2024
Q2
$912 Buy
44
+1
+2% +$20 ﹤0.01% 296
2024
Q1
$817 Hold
43
﹤0.01% 288
2023
Q4
$617 Buy
43
+1
+2% +$14 ﹤0.01% 317
2023
Q3
$725 Buy
42
+1
+2% +$21 ﹤0.01% 272
2023
Q2
$857 Hold
41
﹤0.01% 283
2023
Q1
$955 Buy
41
+1
+3% +$27 ﹤0.01% 216
2022
Q4
$1.12K Buy
+40
New +$1.02K ﹤0.01% 179

Other funds holding OGN

Silicon Valley Capital Partners's OGN Position: Q1 2026 in Review

Silicon Valley Capital Partners increased its Organon & Co (OGN) stake by 1.2% in Q1 2026, buying an estimated $8 and bringing the position to 82 shares worth $490. The position accounts for ﹤0.01% of the portfolio, ranked #367.

Silicon Valley Capital Partners first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.12K in Q4 2022. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Silicon Valley Capital Partners held 82 shares of Organon & Co worth $490 as of Q1 2026.
  • Silicon Valley Capital Partners bought 1 Organon & Co share in Q1 2026, an estimated $8.
  • Organon & Co made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #367 holding.
  • Silicon Valley Capital Partners first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
  • Silicon Valley Capital Partners's Organon & Co position peaked at $1.12K in Q4 2022.
  • 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.